Clinical Trials Directory

Trials / Completed

CompletedNCT01101230

Effects of Almonds on Cardiovascular Risk Factors

Effects of a Diet Rich in Almonds on LDL Cholesterol, LDL Particle Size, Abdominal Adiposity and Vascular Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to build the evidence base for approval of FDA health claims related to almonds and cardiovascular disease. A randomized, 2-period, crossover controlled feeding study was designed to compare the effects of two blood cholesterol lowering diets that meet the American Heart Association recommendations. The nutrient profiles of the control diet (no almonds/day) and almond diet (1.5 oz. of almonds/day) are matched for protein, saturated fat, and cholesterol. The study population consists of two cohorts of 25 men and women with moderately elevated LDL-C. The investigators hypothesize that a cholesterol-lowering diet designed with almonds confers greater cardioprotective effects than a cholesterol-lowering diet without almonds on the basis of the LDL-C lowering response, effect on LDL particle size, abdominal adiposity and vascular health.

Conditions

Interventions

TypeNameDescription
OTHERAlmonds1.5 oz almonds/day

Timeline

Start date
2009-09-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2010-04-09
Last updated
2023-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01101230. Inclusion in this directory is not an endorsement.